Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Alivus Life Sciences Ltd

NSE: ALIVUS · BSE: 543322 · Pharmaceuticals & Biotechnology · 23 announcements

Share price
₹1,370.20
Market cap
₹16,822 Cr
Revenue (annual)
₹2,552 Cr
Net profit (annual)
₹564.5 Cr
P/E (TTM)
27.9×Sector 47.3×
Promoter holding
74.87%+0.00% QoQ
FII holding
5.54%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

19:11 IST BSE
Employee Stock Options

Alivus Life Sciences Employee Stock Options

Alivus Life Sciences allotted 32,000 equity shares under its Employee Stock Option Scheme, 2021. This increases the company's total paid-up share capital.

19:48 IST BSE
Employee Stock Options

Alivus Life Sciences Employee Stock Options

Alivus Life Sciences allotted 3,100 equity shares following employee stock option exercises. This marginal expansion of paid-up capital reflects the ongoing implementation of its ESOP scheme.